Ф. А. Закирова

4 ta ish

Republic Specialized Centre of Cardiology, Tashkent, Uzbekistan

1. ANTIREMODELING EFFICIENCY OF ENALAPRIL IN PATIENTS WITH ESSENTIAL HYPERTENSION WITH ACCOUNT I/D POLYMORPHISM OF ACE-GENE

   G J Abdullaeva, Marietta Eliseyeva, Ф. А. Закирова +1

   MaqolaPharmacogenetics and Drug MetabolismJournal of Hypertension20040 iqtibos

   ABIABI:AkademIndex/openalex/2004.article.000312

2. CLINICAL AND VASOPROTECTIVE EFFICIENCY OF MONOTHERAPY WITH LERCANIDIPINE AND ITS COMBINED USING WITH PERINDOPRIL IN HYPERTENSIVE PATIENTS: PP.5.213

   Ф. А. Закирова, LSH Hafizova, Amayak Kevorkov +1

   MaqolaElectroconvulsive Therapy StudiesJournal of Hypertension20100 iqtibos

   ABIABI:AkademIndex/openalex/2010.article.000397

3. CLINICAL AND VASOPROTECTIVE EFFICIENCY OF COMBINED THERAPY WITH LERCANIDIPINE WITH PERINDOPRIL AND EPROSARTAN IN HYPERTENSIVE PATIENTS

   Lola Khafizova, Ф. А. Закирова, Б. Ш. Каримова +1

   MaqolaBlood Pressure and Hypertension StudiesJournal of Hypertension20110 iqtibos

   ABIABI:AkademIndex/openalex/2011.article.000482

4. ANTIHYPERTENSIVE AND VASOPROTECTIVE EFFICACY OF COMBINED THERAPY WITH LERCANIDIPINE AND PERINDOPRIL IN HYPERTENSIVE PATIENTS

   L. Hafisova, Gulnoz Khamidullaeva, Б. Ш. Каримова +1

   MaqolaBlood Pressure and Hypertension StudiesJournal of Hypertension20110 iqtibos

   ABIABI:AkademIndex/openalex/2011.article.000493